5636 - V-delta-1 T cells are resident in the human lung and associate with survival in patients with non-small cell lung cancer in the TRACERx Study https://www.abstractsonline.com/pp8/#!/10517/presentation/18670
5710 - Identification of convergent gene repression mechanisms through integrative genomic and DNA methylation analysis in TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/18766
5818 - Features of cancer cachexia in non-small cell lung cancer: Insights from the prospective TRACERx study https://www.abstractsonline.com/pp8/#!/10517/presentation/18790
6080 - The heterogeneity and evolution of lung neuroendocrine tumors within TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/18959
6091 - Evolutionary characterisation of lung adenocarcinoma pathological subtypes in TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/18970
6113 - Spatially resolved biomarker detection on single cells in TRACERx using multiplex imaging https://www.abstractsonline.com/pp8/#!/10517/presentation/18032
6217 - TP53 loss with whole genome doubling mediates heterogeneous intra-patient therapy response in EGFR-driven lung adenocarcinoma: A TRACERx study https://www.abstractsonline.com/pp8/#!/10517/presentation/19053
LB504 - Automated grading of growth patterns in lung adenocarcinoma-from TRACERx to LATTICe-A https://www.abstractsonline.com/pp8/#!/10517/presentation/19990
Lung cancer evolution and its prognostic impact https://www.abstractsonline.com/pp8/#!/10517/presentation/435
692 - Patient-derived co-cultures of TRACERx lung cancer organoids and autologous T-cells reveal heterogeneity in immune evasion between cancer subclones https://www.abstractsonline.com/pp8/#!/10517/presentation/13698
645 - Heterogeneity of immunotherapy biomarkers in the TRACERx non-small cell lung cancer multi-region lung cancer cohort study https://www.abstractsonline.com/pp8/#!/10517/presentation/12564
674 - Tracking the transcriptome of lung cancer-associated fibroblasts within the TRACERx lung study from patient to culture models reveals phenotypic plasticity and instructive cues from cancer cells https://www.abstractsonline.com/pp8/#!/10517/presentation/13235
1211 / 7 - Allele-specific copy-number based deconvolution of bulk tumour RNA sequencing data from the TRACERx study https://www.abstractsonline.com/pp8/#!/10517/presentation/15832
1394 / 25 - Pervasive allele specific transcriptional repression of the class I and II HLA genes in TRACERx non-small cell lung cancer https://www.abstractsonline.com/pp8/#!/10517/presentation/14639
1591 / 6 - Convergence of antigenic diversity and Tex-cell stability fatally constrains immune surveillance in non-small cell lung cancer (TRACERx) and HIV-1 infection (Protocol C) https://www.abstractsonline.com/pp8/#!/10517/presentation/14124
1603 / 18 - Genomic transcriptomic evolution in TRACERx lung cancer and metastasis https://www.abstractsonline.com/pp8/#!/10517/presentation/14137
1699 / 16 - SignaTree: A tool to identify evolutionary trajectories of the activity of mutational processes in TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/14141
1926 / 5 - Machine learning-enhanced image and spatial analytic pipelines for imaging mass cytometry applied to the TRACERx non-small cell lung cancer study https://www.abstractsonline.com/pp8/#!/10517/presentation/14797
2197 - Targeted cancer therapy induces APOBEC fueling the evolution of drug resistance https://www.abstractsonline.com/pp8/#!/10517/presentation/13694
2144 - Holistic sampling of clonal dynamics using cfDNA in lung TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/12566
2784 / 18 - A robust copy number based clonality classification for multiple pulmonary tumors in routine pathology practice by shallow next generation sequencing of formalin fixed clinical specimens https://www.abstractsonline.com/pp8/#!/10517/presentation/12713
3043 / 1 - Exploring the microbial landscape of NSCLC through TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/11523
3096 / 3 - Multi-region patient-derived xenograft models from non-small cell lung cancer patients enrolled in lung TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/14356
LB153 / 6 - Clinical relevance of spatial intermixing of growth patterns and immune infiltration in lung adenocarcinoma-from TRACERx to LATTICe-A https://www.abstractsonline.com/pp8/#!/10517/presentation/20375
3626 - Genomic evolutionary patterns in matched pre-invasive and invasive lung disease in TRACERx https://www.abstractsonline.com/pp8/#!/10517/presentation/16334
3609 - Defining extrinsic and intrinsic mechanisms of immune evasion in TRACERx using imaging mass cytometry https://www.abstractsonline.com/pp8/#!/10517/presentation/13896
3792 / 5 - TRACERx: Mapping the evolution of metastases in non-small cell lung cancer https://www.abstractsonline.com/pp8/#!/10517/presentation/14147
Recent ACHL News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 03/21/2025 01:41:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/20/2025 09:30:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/19/2025 08:16:04 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
